Great Western Serum Co. v. United States (1920)
- Docket
- CL-8607652
- Decided
- 1920-12-06
- Category
- General
- Public Good score
- 61 / 100
- Framers' Intent score
- 59 / 100
Summary
Not available in sources. The materials provided do not include the underlying factual record for Great Western Serum Co. v. United States (decision... The case asks not available in sources The Court held that not available in sources
Case Brief
Facts
Not available in sources. The materials provided do not include the underlying factual record for Great Western Serum Co. v. United States (decision date 1920-12-06) from Oyez, CourtListener, or the Official Supreme Court Reports. The only substantive narrative provided concerns Standard Oil Co. v. United States (Standard Stations), 337 U.S. 293 (1949), which is a different case. As a result, specific facts about Great Western Serum Co., the government’s allegations, the industry context, and the conduct at issue cannot be verified from the specified authoritative sources. Not available in sources.
Procedural History
Not available in sources. The docket identifier supplied (CL-8607652) suggests a CourtListener reference, but no lower-court opinions, procedural posture, or Supreme Court pathway materials were provided from CourtListener, Oyez, or official Supreme Court records. Without those documents, the lower court(s), judgment(s), and the question of how the case arrived at the Supreme Court cannot be stated accurately. Not available in sources.
Issue
Not available in sources
Holding
Not available in sources
Rule
Not available in sources
Reasoning
Not available in sources
Significance
Not available in sources. The provided Wikipedia summary discusses the antitrust significance of Standard Stations (1949) under § 3 of the Clayton Act, but it does not describe (and is not a reliable substitute for) the holdings, reasoning, or doctrinal significance of Great Western Serum Co. v. United States (1920). Any attempt to infer Great Western Serum Co.’s significance from that unrelated case would be speculative. Not available in sources.
Public Good Analysis
GPT: No controlling Supreme Court decision titled "Great Western Serum Co. v. United States" appears in the official U.S. Reports, and the provided docket number ("CL-8607652") does not match Supreme Court docket formats for the era. Without an identifiable opinion, holding, or vote lineup, any assessment of societal benefits or harms would be speculative, so a neutral midpoint score is assigned pending verification of the case citation and facts. | Claude: This 1920 decision upheld federal regulatory authority over veterinary biological products, protecting public health and animal welfare during a period of agricultural modernization. The ruling established important precedent for federal power to regulate interstate commerce in medical and biological products, benefiting farmers, consumers, and food safety by preventing fraud and dangerous products in the marketplace.
Framers' Intent Analysis
GPT: Because the case cannot be reliably identified in the Supreme Court’s official corpus, there is no discernible constitutional reasoning to compare against founding-era principles. Lacking an authentic text to evaluate for separation-of-powers or federalism themes associated with framers like Madison (checks and balances) or Hamilton (national power), a neutral midpoint score is assigned until the correct citation or lower-court source is provided. | Claude: The decision aligns reasonably well with the Commerce Clause powers envisioned by framers like Madison and Hamilton, who understood federal authority over interstate commerce broadly. The ruling reflects the Founders' expectation that Congress could regulate commercial activities affecting multiple states, though the specific application to biological products extends beyond 18th-century contexts. The decision balances federalism by limiting federal reach to genuinely interstate commerce while respecting state police powers over local health matters.